61
Medical Immunology Department of Immunology Yiwei Chu 储储储 [email protected] 2010-7-7

Medical Immunology Department of Immunology Yiwei Chu 储以微 [email protected] 2010-7-7

Embed Size (px)

Citation preview

Page 1: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Medical ImmunologyDepartment of Immunology

Yiwei Chu储以微

[email protected]

2010-7-7

Page 2: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Exam: 9th July (Friday)

8:30-10:30am

Inspector: Dr. Lu Qing Dr. Gao Bao

2010-7-7

Page 3: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Department of Immunology

Rui He

Xiaowu HongQing Lu

Bo Gao

Wei Xu

Yiwei Chu

Haifeng Gao

Yunlu Lin

Page 4: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

IMMUNITY ---protection from disease (infectious disease)

IMMUNE SYSTEM --- organ, cell, molecule and gene

IMMUNE RESPNSE --- response to the foreign substances

Define of Immunology

Page 5: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

IMMUNE FUNCTIONS

---immune defence (infectious disease)

--- immune surveillance

--- immune homeostasis

Define of Immunology

Page 6: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

IMMUNITY ---protection from disease (infectious disease)

IMMUNE SYSTEM --- organ, cell, molecule and gene

IMMUNE RESPNSE --- response to the foreign substances

Define of Immunology

Page 7: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Innate and Adaptive Immunity

Page 8: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Adaptive Immune Responses

Page 9: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Cellular Components

Adaptive Immune Responses

• Lymphocytes - B, Th, CTL, NKT

• Antigen-presenting cells(APCs)- DC, Mj, B

• Effector cells - Activated T cells, mononuclear phagocytes

Page 10: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Basic Immunology

Recognition Activation Effection

Ag (antigen) double recognition humural immunity

APC double signaling cellular immunity

(antigen presenting cell)

Page 11: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Antigen (Ag)

Chapter 1 Definition of antigen

Substances that combine specifically

with a B or T cell’s antigen-binding

receptors can then induce an immune

response are called antigens.

Page 12: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Chapter 2 Characteristics of antigen

( 1 ) immunogenicity

( 2 ) antigenicity

The antigen molecule generally pose two natures, that is

Page 13: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Antigenic determinants or epitopes are the

immunologically active regions of an

immunogen that bind to antigen-specific

membrane receptors on lymphocytes

(TCR/BCR) or to secreted antibodies.

(1) Antigenic determinants or epitopes

Page 14: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

1 Conformational epitope

Nonsequential polypeptides or polysaccharide on the

surface of the molecules,

Native conformation,

2 liner epitope

A sequential amino acid fragment,

Linear determinant,

Inside of the antigen molecule

Structure of epitopes

Page 15: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

(complimentarity

determining region,

CDR) :

formation of the Ag binding site

Framework region ( FR ) :

maintaining the 3- dimensional configuration

(3) hypervarible region (HVR)

Page 16: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

(complimentarity determining region,) CDR

Page 17: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

4. Ab-dependent Cell-mediated cytotoxicity, ADCC

enhance NK killing

Page 18: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Immune Responses to Tumors

Page 19: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

APCs are immunocytes that can uptake,

process and present antigens to other

lymphocytes.

CONCEPT

Page 20: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Dendritic Cells (DCs)

Macrophages (M)

B Lymphocytes

Professional APCs

Page 21: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Ralph.M.Steinman, 1973

I. Dendritic Cells (DCs)

Page 22: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

The invariant chain is cleaved to leave a peptide fragment, CLIP, bound to the

MHC class II molecule

CLIP (class II-associated invariant-chain peptide)

Page 23: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

MHC class II molecule combined with peptide

Page 24: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7
Page 25: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7
Page 26: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Cytokines are polypeptides produced by the cells of innate and adaptive immunity in response to microbes and other antigens as a result of cellular activation.

Cytokines initiate their actions by binding to specific membrane receptors on target cells.

The cellular responses to most cytokines consist of gene activation, resulting in the expression of new functions and sometimes the proliferation of the target cells

What are cytokines?

Page 27: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Cytokine actions may be local and systemic

Autocrineaction

Endocrine action

circulation

act at a distance from the site of infection

Paracrine action act on a nearby cell

act on cytokine-producing cell itself

Page 28: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

inflammation

BloodSecondary lymphoid organs

Primary lymphoid organs

Tissue

directing migration of leukocytesChemokines

Physiologic traffic of lymphocytes through the organs

(1) inflammatory stimuli

(2) Constitutively produced in lymphoid organs

to inflammatory sites

Cellular sources

Page 29: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

IL-2

• a growth factor for antigen-stimulated T lymphocytes

• responsible for T cell clonal expansion after antigen recognition

Page 30: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Natural Killer cells (NK cells)

A type of cytotoxic lymphocytes

The principal physiologic role1. Defense against infections by viruses and some other intracelluar

microbes

2. Rejection of tumors

Page 31: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

The mechanism of effector function

Perforin

Granzyme

Page 32: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Pathogen-associated molecular patterns (PAMPs)

Small molecular motifs conserved within a class of

microbes

Usually essential for survival of the microbes

Recognized by cells of innate immune system

Activate innate immune response

Page 33: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

PAMPs Source Principle innate immune response

LPS Gram-negative bacteria Macrophage activationcell wall

dsRNA Replicating viruses Type I IFN production by infected cells

Unmethylated CpG DNA

Bacterial DNA Macrophage activation

N-formylmethionine Bacteria protein neutrophil and macrophage activation

Mannose-richglycans

Microbial glycoproteins phgocytosisor glycolipid opsonization complement activation

Examples of PAMPs

Page 34: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Patterns recognition receptors (PRRs)

Proteins expressed by cells of innate immune system

Present on the cell surface, in endosomal vesicles, and

in the cytoplasm

Page 35: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

The subsets of CD4+Th cells

How they are induced, What cytokines they produce What effector mechanisms they activate

Page 36: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Development of Th1 and Th2 subsets

Page 37: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Membrane Ig (mIg)

Mature B cell : mIgM + mIgD

BCR-Igα/Igβ complex

BCR/mIgM

Surface receptor

1) B cell antigen receotor (BCR)

Page 38: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

BCR-Iga/Igb complex

Page 39: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

2. BCR coreceptor

CD19 B-specific surface marker

signal transduction

CD21 CR2 , receptor for C3d-bound Ag

CD81 BCR - coreceptor ligation

induce reversible palmitoylation of CD81

to stabilize the CD19/CD21/CD81 complex

Help and strengthen the BCR-Ag-signaling

JBC 2004;279:31973

Page 40: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

B cell activation

B cell epitope

BCR-Iga/Igb coreceptor complex

Page 41: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

TCR-CD3BCR-Iga/b

Page 42: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Two-signal activation model for T cells

naive

activation

co-stimulatory molecules

anergynone

Page 43: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Two-signal activation model for B cells

Signal 1 and signal 2 are not simultaneous

But in two steps, signal 2 from Th cells

Signal 3

Page 44: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

B-1 cells ( peritoneal cavity ) marginal zone (MZ) B cells ( spleen )

frequent Ag encounter. Secreting essentially germline-encoded, polyreactive natural Abs, respond rapidly and vigorously to pathogens

express Toll-like receptors (TLR),provide costimulation to GC B cellsimportant link between the innate and adaptive immunity

MZ B cells

innate immune functions

Page 45: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

location mucosal sites spleen, LN

Ig-producing way naturally Ag-inductive

specificity poly-reactive highly specific

Ag TI Ag TD Ag

( polysaccharide )

Ig class Ig M IgG

affinity low high

B1 B2/FO B

Page 46: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Significance of humoral immunity

eliminate extracellular bacterium and toxin

eliminate extracellular virus

Page 47: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Antigen crosslinks mIg(BCR), generating signal 1, which leads to increased expression of class II MHC and costimulatory B7.

Antigen–BCR complexes are internalized by receptor-mediated endocytosis and degraded to peptides, which are bound by class II MHC and presented as peptide–MHC complexes.

Th cell recognizes Ag–class II MHC and B7-CD28 co-stimulation on B-cell membrane which activates TH cell.

Th cell begins to express CD40L.Interaction of CD40 and CD40L provides signal 2.

Th cell release large quantities of cytokines(IL-4) signal 3 to support the progression of the B cell replication and differentiation.

Page 48: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Early events :follicle ( B ) -paracortex ( T ) border,

B activation and T-B activation

Small amounts of Ab production

Late events :At the germinal center

Presence of Ag and Th

Affinity maturation

Ig class switch (IgM IgG)

Memory B

Early and late event in Ab response to TD antigen

Page 49: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

General Features and Mechanisms

Immunologically specificCentral tolerance:

induced in generative lymphoid organs immature self-reactive lymphocyte

The repertoire of mature lymphocytes cannot recognize ubiquitous or widely disseminated self antigens The repertoire of mature lymphocytes cannot recognize ubiquitous or widely disseminated self antigens

Page 50: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

T Lymphocyte Tolerance

Central T Cell Tolerance Peripheral T cell Tolerance

Page 51: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Burnet: Clonal selection hypothesis

Page 52: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Peripheral T cell Tolerance

Antigen recognition without adequate costimulationUse CTLA-4 to recognize costimulators on APCsActivation induced cell death (AICD)Regulatory T LymphocytesFactors that determine the tolerogenicity of self antigens

Page 53: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Tumor Antigen

• Tumor-specific antigen

Antigen that are expressed on tumor cells but not on normal cells

were called tumor- specific antigens; some of these antigens are

unique to individual tumors, whereas others are shared among

tumors of the same type.

Page 54: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Tumor Antigen

• Tumor-associated antigen

Tumor antigens that are also expressed on normal cells were called

tumor-associated antigens; in most cases, these antigens are

normal cellular constituents whose expression is aberrant or

dysregulated in tumors

Page 55: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Evasion of Immune Responses

Class I MHC expression may be down-regulated on tumor cells so that they cannot be recognized by CTLs.

Tumor lose expression of antigen that elicit immune responses.

Tumors may fail to induce CTLs because most tumor cells do not express costimulators or class II MHC molecules.

The products of tumor cells may suppress antitumor immune responses.

Tumor antigens may induces may induce specific immunologic tolerance.

Page 56: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

57

Difference between Direct Recognition and Indirect Recognition

Direct Recognition

Indirect Recognition

Allogeneic MHC molecule

Intact allogeneic MHC molecule

Peptide of allogeneic MHC molecule

APCs Recipient APCs are not necessary

Recipient APCs

Roles in rejection Acute rejection Chronic rejection

Degree of rejection Vigorous Weak

Page 57: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

58

Host versus graft reaction (HVGR) Conventional organ

transplantation

Graft versus host reaction (GVHR) Bone marrow transplantation Immune cells transplantation

Classification of Allograft Rejection

Page 58: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

59

Conditions

Enough immune competent cells in grafts

Immunocompromised host

Histocompatability differences between host and graft

II.Graft versus host reaction (GVHR)

Page 59: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Hypersensitivity

Tissue injury caused by an immune response that is inadequately controlled or inappropriately targeted to host tissues

Page 60: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

Type I: ImmediateType II: CytotoxicType III: Immune complex

Type IV: cell mediated or delayed

GELL AND COOMB’S CLASSIFICATION

Types of hypersensitivity reactions

Page 61: Medical Immunology Department of Immunology Yiwei Chu 储以微 ywchu@shmu.edu.cn 2010-7-7

THANK YOU

THANK YOU